Company intelligence / Profile preview

Apollo Health Ventures

Hamburg, Hamburg, Germanyapollo.vc ↗

Ownership: Private
Development stage: Other

Overview

Apollo Health Ventures does not conduct clinical trials itself but invests in and co-founds early-stage biotech companies developing therapeutics targeting age-related diseases. Its portfolio includes programs in preclinical through early clinical stages with several notable advances such as first-in-human dosing and FDA Fast Track designations for cancer therapies.

Therapeutic areas: OtherOncologyNeurology
Modalities: Small moleculeBiologicRNA therapyPeptide
Industry: Investors

Partnerships

Leading research institutes/universities

Beyond the preview

Go deeper on Apollo Health Ventures.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Apollo Health Ventures.

Explore the full profile